Song Guoyuan, Liu Xiujuan, Lu Zihe, Guan Jingyue, Chen Xinyue, Li Yichen, Liu Gang, Wang Gang, Ma Fangfang
Department of Cardiology, The First Hospital of Hebei Medical University, 89 Donggang Road, Shijiazhuang, 050000, Hebei, China.
Department of Intensive Care Unit, The First Hospital of Qinhuangdao, 258 Wenhua Road, Qinhuangdao, 066000, Hebei, China.
Cardiovasc Diabetol. 2025 May 2;24(1):188. doi: 10.1186/s12933-025-02751-3.
Stress-induced hyperglycemia (SIH) is a physiological response to acute or chronic stress characterized by elevated blood glucose levels. It is prevalent in both patients with and without diabetes, particularly those with acute or critical illnesses. The development of SIH is characterized by complex interactions among catecholamines, cortisol, and inflammatory mediators such as cytokines, resulting in increased hepatic glucose production and insulin resistance. While mild to moderate SIH may provide a protective mechanism during stress, prolonged or excessive hyperglycemia can exacerbate inflammation and oxidative stress, contributing to adverse outcomes in conditions such as acute myocardial infarction, heart failure, and cerebrovascular diseases. The stress-hyperglycemia ratio (SHR), defined as the ratio of admission glucose to estimated mean glucose (derived from glycated hemoglobin [HbA1c]), has emerged as a valuable tool for quantifying stress hyperglycemia. Unlike absolute glucose levels, the SHR accounts for background hyperglycemia and provides a more accurate indicator of the relative glucose elevation associated with critical illness. Extensive research has demonstrated a U-shaped or J-shaped relationship of the SHR with disease outcomes, indicating that both low and high SHRs are associated with increased mortality and morbidity. The SHR has shown significant predictive value in cardiovascular diseases (e.g., acute coronary syndrome, heart failure), cerebrovascular diseases (e.g., acute ischemic stroke, intracerebral hemorrhage), and infectious diseases (e.g., sepsis, pneumonia). It also plays a role in other conditions, such as acute pancreatitis and certain cancers. The ease of calculating the SHR from widely available admission glucose and HbA1c tests makes it a practical and valuable prognostic marker in clinical settings. This review examines the relationship between the SHR and critical illnesses, highlighting its mechanisms and predictive value across various diseases.
应激性高血糖(SIH)是机体对急性或慢性应激的一种生理反应,其特征为血糖水平升高。它在糖尿病患者和非糖尿病患者中均普遍存在,尤其是患有急性或危重症的患者。SIH的发生特点是儿茶酚胺、皮质醇和细胞因子等炎症介质之间存在复杂的相互作用,导致肝脏葡萄糖生成增加和胰岛素抵抗。虽然轻度至中度的SIH在应激期间可能提供一种保护机制,但长期或过度的高血糖会加剧炎症和氧化应激,在急性心肌梗死、心力衰竭和脑血管疾病等情况下导致不良后果。应激 - 高血糖比值(SHR),定义为入院血糖与估计平均血糖(由糖化血红蛋白[HbA1c]得出)的比值,已成为量化应激性高血糖的一种有价值的工具。与绝对血糖水平不同,SHR考虑了基础高血糖情况,并提供了一个更准确的指标来反映与危重症相关的相对血糖升高。广泛的研究表明SHR与疾病预后呈U形或J形关系,这表明低SHR和高SHR均与死亡率和发病率增加有关。SHR在心血管疾病(如急性冠状动脉综合征、心力衰竭)、脑血管疾病(如急性缺血性中风、脑出血)和传染病(如脓毒症、肺炎)中显示出显著的预测价值。它在其他病症中也发挥作用,如急性胰腺炎和某些癌症。通过广泛可用的入院血糖和HbA1c检测来计算SHR很容易,这使其成为临床环境中一种实用且有价值的预后标志物。本综述探讨了SHR与危重症之间的关系,强调了其在各种疾病中的机制和预测价值。